HALEON Pharmaceuticals: Major
Health Technology
Mkt Cap
89.0B
P/E (TTM)
13.58
EPS
54.45
ROE
50.11%
Div Yield
3.95%
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Return on Equity (ROE) | 47.59% | 45.76% | 13.22% | 4.73% | 35.93% | |
| Return on Assets (ROA) | 25.71% | 22.57% | 5.89% | 2.22% | 17.08% | |
| Return on Invested Capital | 46.88% | 44.87% | 12.95% | 4.69% | 35.93% | |
| Gross Margin | 37.33% | 32.86% | 19.67% | 16.98% | 26.69% | |
| Operating Margin | 23.28% | 18.22% | 4.88% | 3.75% | 11.48% | |
| EBITDA Margin | 24.69% | 19.67% | 6.25% | 4.96% | 12.72% | |
| Net Margin | 14.78% | 12.31% | 3.15% | 1.18% | 8.83% | |
| Pre-Tax Margin | 24.65% | 20.51% | 5.82% | 3.61% | 12.48% | |
| Liquidity | ||||||
| Current Ratio | 1.57 | 1.54 | 1.32 | 1.42 | 1.46 | |
| Quick Ratio | 0.87 | 0.95 | 0.72 | 0.79 | 0.84 | |
| Leverage | ||||||
| Debt / Equity | 0.02 | 0.02 | 0.03 | 0.02 | 0.00 | |
| Debt / Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |
| LT Debt / Equity | 0.01 | 0.02 | 0.02 | 0.02 | 0.00 | |
| LT Debt / Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |
| Net Debt | -7.47B | -6.54B | -4.21B | -3.56B | -3.35B | |
| Total Debt | 250.30M | 249.29M | 232.25M | 155.17M | 0 | |
| Efficiency | ||||||
| Asset Turnover | 1.74 | 1.83 | 1.87 | 1.88 | 1.93 | |
| Inventory Turnover | 4.07 | 4.50 | 4.79 | 5.00 | 4.69 | |
| Per Share | ||||||
| Book Value Per Share | 126.41 | 102.42 | 68.54 | 60.16 | 57.37 | |
| Tangible Book Per Share | 125.32 | 101.32 | 67.23 | 59.07 | 56.28 | |
| Cash Per Share | 65.99 | 58.01 | 37.91 | 31.77 | 28.65 | |
| Total Debt Per Share | 2.14 | 2.13 | 1.98 | 1.33 | 0.00 | |
| Working Capital Per Share | 55.31 | 41.26 | 26.43 | 27.80 | 27.04 | |
| Shares & Market | ||||||
| Total Shares Outstanding | 117,054,508 | 117,054,508 | 117,054,508 | 117,054,508 | 117,054,508 | |
| Market Cap | 97.54B | 94.54B | 19.78B | 19.19B | 28.22B | |
| Enterprise Value | 90.07B | 88.00B | 15.58B | 15.62B | 24.86B | |
| Employees | 447 | 447 | 452 | 478 | 459 | |
| Shareholders | 5,124 | 5,124 | 5,124 | 5,124 | 5,124 | |